3 reasons why I own Healthscope Ltd shares

Healthscope Ltd (ASX:HSO) could have a healthy future.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are some so-called tailwinds that don't really mean much, but the ageing population tailwind could be a really good one.

One of the industries that could be the biggest beneficiaries is the healthcare industry, particularly private hospital operators.

Here's why I think Healthscope Ltd (ASX: HSO) is a good choice for my portfolio:

Ageing population

Like I just mentioned, Healthscope is a clear beneficiary from the ageing population.

The over-65 segment of the population is sadly the most likely to need to visit a hospital.

The number of people over 65 is expected to grow by 75% over the next two decades, which suggests Healthscope's hospitals are just going to get busier from here.

Hospital construction and expansion

One of the main reasons I think Healthscope could be a market-beating opportunity is that it has an impressive list of projects which will increase the number of hospital beds and operating theatres.

Management have outlined that by FY19 it will have added another 566 hospital beds and 38 operating theatres, which should be a good boost to the bottom and top lines when all of them are complete.

Public hospital

One interesting aspect about Healthscope is that its large Northern Beaches Hospital project will be a public and private hospital.

Healthscope has been contracted by the New South Wales Government to design, build, operate and maintain the hospital. Healthscope has long-term contracts to operate it, the public contract is for 20 years and the private contract is for 40 years.

The catchment area has around 250,000 people with a private health insurance participation rate of more than 60%, which is significantly higher than the national average.

Foolish takeaway

Healthscope is currently trading at 19x FY18's estimated earnings with an unfranked dividend yield of 3.59%. Although $1.95 isn't as good of a price as $1.65 a couple of months ago, I think Healthscope could be a solid investment today.

Motley Fool contributor Tristan Harrison owns shares of HEALTHSCPE DEF SET. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »